{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:29:50Z","timestamp":1791491390694,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,26]]},"DOI":"10.7759\/cureus.14686","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T07:07:55Z","timestamp":1619420875000},"source":"Crossref","is-referenced-by-count":6,"title":["Metabolically Supported Chemotherapy for Managing End-Stage Breast Cancer: A Complete and Durable Response"],"prefix":"10.7759","author":[{"given":"Mehmet Salih","family":"\u0130yikesici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Kadir","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasha","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Kalamian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-42. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pky062","article-title":"Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review","volume":"2","author":"Caswell-Jin JL","year":"2018","unstructured":"Caswell-Jin JL, Plevritis SK, Tian L, et al.. Change in survival in metastatic breast cancer with treatment advances: meta-analysis and systematic review. JNCI Cancer Spectr. 2018, 2:pky062. 10.1093\/jncics\/pky062","journal-title":"JNCI Cancer Spectr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg O","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956, 123:309-14. 10.1126\/science.123.3191.309","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-7-7","article-title":"Cancer as a metabolic disease","volume":"7","author":"Seyfried TN","year":"2010","unstructured":"Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutr Metab (Lond). 2010, 7:7. 10.1186\/1743-7075-7-7","journal-title":"Nutr Metab (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00021","article-title":"Consideration of ketogenic metabolic therapy as a complementary or alternative approach for managing breast cancer","volume":"7","author":"Seyfried TN","year":"2020","unstructured":"Seyfried TN, Mukherjee P, Iyikesici MS, Slocum A, Kalamian M, Spinosa JP, Chinopoulos C. Consideration of ketogenic metabolic therapy as a complementary or alternative approach for managing breast cancer. Front Nutr. 2020, 7:21. 10.3389\/fnut.2020.00021","journal-title":"Front Nutr"},{"key":"ref6","article-title":"Long-term outcomes of the treatment of unresectable (stage III-IV) ductal pancreatic adenocarcinoma using metabolically supported chemotherapy (MSCT): a retrospective study","volume":"17","author":"Iyikesici MS","year":"2016","unstructured":"Iyikesici MS, Slocum A, Turkmen E, et al.. Long-term outcomes of the treatment of unresectable (stage III-IV) ductal pancreatic adenocarcinoma using metabolically supported chemotherapy (MSCT): a retrospective study. J Pancreas. 2016, 17:36-41.","journal-title":"J Pancreas"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.16966\/2381-3318.120","article-title":"Complete response of locally advanced (stage III) rectal cancer to metabolically supported chemoradiotherapy with hyperthermia","volume":"2","author":"Iyikesici M","year":"2016","unstructured":"Iyikesici M, Slocum A, Turkmen E, Akdemir O, Slocum A, Berkarda F. Complete response of locally advanced (stage III) rectal cancer to metabolically supported chemoradiotherapy with hyperthermia. Int J Cancer Res Mol Mech. 2016, 2:1-4. 10.16966\/2381-3318.120","journal-title":"Int J Cancer Res Mol Mech"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1445","article-title":"Efficacy of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy for stage IV triple-negative breast cancer","volume":"9","author":"\u0130yikesici MS","year":"2017","unstructured":"\u0130yikesici MS, Slocum AK, Slocum A, Berkarda FB, Kalamian M, Seyfried TN. Efficacy of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy for stage IV triple-negative breast cancer. Cureus. 2017, 9:e1445. 10.7759\/cureus.1445","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2019.1589584","article-title":"Feasibility study of metabolically supported chemotherapy with weekly carboplatin\/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer","volume":"36","author":"Iyikesici MS","year":"2019","unstructured":"Iyikesici MS. Feasibility study of metabolically supported chemotherapy with weekly carboplatin\/paclitaxel combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in metastatic non-small cell lung cancer. Int J Hyperthermia. 2019, 36:446-55. 10.1080\/02656736.2019.1589584","journal-title":"Int J Hyperthermia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000502135","article-title":"Long-term survival outcomes of metabolically supported chemotherapy with gemcitabine-based or FOLFIRINOX regimen combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in metastatic pancreatic cancer","volume":"27","author":"Iyikesici MS","year":"2020","unstructured":"Iyikesici MS. Long-term survival outcomes of metabolically supported chemotherapy with gemcitabine-based or FOLFIRINOX regimen combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in metastatic pancreatic cancer. Complement Med Res. 2020, 27:31-39. 10.1159\/000502135","journal-title":"Complement Med Res"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.4103\/njcp.njcp_509_18","article-title":"Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer","volume":"23","author":"Iyikesici MS","year":"2020","unstructured":"Iyikesici MS. Survival outcomes of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia, and hyperbaric oxygen therapy in advanced gastric cancer. Niger J Clin Pract. 2020, 23:734-40.","journal-title":"Niger J Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.25000\/acem.650341","article-title":"Preliminary results of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in stage II-IV rectal cancer","volume":"5","author":"\u0130yikesici MS","year":"2020","unstructured":"\u0130yikesici MS. Preliminary results of metabolically supported chemotherapy combined with ketogenic diet, hyperthermia and hyperbaric oxygen therapy in stage II-IV rectal cancer. Arch Clin Exp Med. 2020, 5:16-20. 10.25000\/acem.650341","journal-title":"Arch Clin Exp Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-017-0178-2","article-title":"Press-pulse: a novel therapeutic strategy for the metabolic management of cancer","volume":"14","author":"Seyfried TN","year":"2017","unstructured":"Seyfried TN, Yu G, Maroon JC, D'Agostino DP. Press-pulse: a novel therapeutic strategy for the metabolic management of cancer. Nutr Metab (Lond). 2017, 14:19. 10.1186\/s12986-017-0178-2","journal-title":"Nutr Metab (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101761","article-title":"On the origin of ATP synthesis in cancer","volume":"23","author":"Seyfried TN","year":"2020","unstructured":"Seyfried TN, Arismendi-Morillo G, Mukherjee P, Chinopoulos C. On the origin of ATP synthesis in cancer. iScience. 2020, 23:101761. 10.1016\/j.isci.2020.101761","journal-title":"iScience"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.07.015","article-title":"Metabolic therapy: a new paradigm for managing malignant brain cancer","volume":"356","author":"Seyfried TN","year":"2015","unstructured":"Seyfried TN, Flores R, Poff AM, D'Agostino DP, Mukherjee P. Metabolic therapy: a new paradigm for managing malignant brain cancer. Cancer Lett. 2015, 356:289-300. 10.1016\/j.canlet.2014.07.015","journal-title":"Cancer Lett"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/02656730802610357","article-title":"Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results","volume":"25","author":"Ohguri T","year":"2009","unstructured":"Ohguri T, Imada H, Narisada H, et al.. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results. Int J Hyperthermia. 2009, 25:160-67. 10.1080\/02656730802610357","journal-title":"Int J Hyperthermia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(04)81023-1","article-title":"Tumor hypoxia and malignant progression","volume":"381","author":"Vaupel P","year":"2004","unstructured":"Vaupel P, Mayer A, H\u00f6ckel M. Tumor hypoxia and malignant progression. Methods Enzymol. 2004, 381:335-54. 10.1016\/S0076-6879(04)81023-1","journal-title":"Methods Enzymol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.01.001","article-title":"Hyperbaric oxygenation for tumour sensitisation to radiotherapy: a systematic review of randomised controlled trials","volume":"34","author":"Bennett M","year":"2008","unstructured":"Bennett M, Feldmeier J, Smee R, Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy: a systematic review of randomised controlled trials. Cancer Treat Rev. 2008, 34:577-91. 10.1016\/j.ctrv.2008.01.001","journal-title":"Cancer Treat Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0061-0","article-title":"Fasting and cancer: molecular mechanisms and clinical application","volume":"18","author":"Nencioni A","year":"2018","unstructured":"Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer. 2018, 18:707-19. 10.1038\/s41568-018-0061-0","journal-title":"Nat Rev Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16138-3","article-title":"Fasting mimicking diet as an adjunct to\u2009neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial","volume":"11","author":"de Groot S","year":"2020","unstructured":"de Groot S, Lugtenberg RT, Cohen D, et al.. Fasting mimicking diet as an adjunct to\u2009neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun. 2020, 11:3083. 10.1038\/s41467-020-16138-3","journal-title":"Nat Commun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55013-metabolically-supported-chemotherapy-for-managing-end-stage-breast-cancer-a-complete-and-durable-response","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:06Z","timestamp":1707506886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55013-metabolically-supported-chemotherapy-for-managing-end-stage-breast-cancer-a-complete-and-durable-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.14686","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,26]]}}}